1WHO. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization 2011.
2Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859): 2095-128.
3WHO. Cardiovascular diseases mortality: Age-standardized death rate per 100 000 population, 2010-2012. Geneva: World Health Organization 2012.
4Kilic U, Gok O, Bacaksiz A, Izmirli M, Elibol-Can B, Uysal O. SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases. PLoS One 2014, 9(2): e90428.
5Iaconetti C, Gareri C, Polimeni A, Indolfi C. Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology. Int J Mol Sci 2013, 14(10): 19987-20018.
6Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316(5830): 1484-8.
7Dillmann W. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 2010, 15(2): 125-32.
8Hung T, Chang HY. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol 2010, 7(5): 582-5.
9Leung A, Trac C, Jin W, Lanting L, Akbany A, Saetrom P, et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 2013, 113(3): 266-78.
10Berghoff EG, Clark MF, Chen S, Cajigas I, Leib DE, Kohtz JD. Evf2 (Dlx6as) lncRNA regulates ultraconserved enhancer methylation and the differential transcriptional control of adjacent genes. Development 2013, 140(21): 4407-16.
